The ASCO Nominating Committee has selected 13 distinguished members as candidates for open leadership positions within the Society. ASCO encourages all eligible members to cast their ballots to choose ...

The American Society of Clinical Oncology (ASCO) is offering free One-Day Quality Training Program Workshops throughout the United States! This is an oncology-focused introduction to quality ...

Conquer Cancer®, the ASCO Foundation and Pfizer Inc. are collaborating to offer a Quality Improvement grant funding opportunity for healthcare systems, hospitals, cancer centers and other patient care ...

Regular abstracts are released on ASCO's Digital Program; Late-Breaking Abstracts (LBAs) will be released at 7:00 AM (PT) on their day of presentation at the meeting ...

Conquering cancer through research, education, and promotion of the highest quality patient care. ASCO is supported by its affiliate organization, Conquer Cancer, the ASCO Foundation, which funds ...

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

Federal funding propels cancer research forward — it fuels breakthroughs, drives progress, and brings us closer to conquering cancer. Federal research is on the chopping block for Fiscal Year (FY) ...

Can I attend the Symposium online? Yes, the Symposium is taking place both in-person and online. Please visit the Registration page for more information. Can I change my attendance type from online to ...

Abstract Submission Deadline: September 9, 2025, at 11:59 PM (EST) Late-Breaking Abstract Submission Deadline: October 9, 2025, at 12:00 PM (EST) Company: an entity whose business is developing, ...

Who does this study affect? People with high-risk stage II or stage III colon cancer that has been treated with surgery and chemotherapy When colon cancer has not spread to distant parts of the body, ...

What did this study find? A large observational study of more than 170,000 people with diabetes and obesity found that treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist may modestly ...

ASCO Direct™ is a flexible and customized program that provides a timely blend of the most relevant scientific highlights and perspectives from the ASCO Annual Meeting or symposia in the local ...